Latest News

Biosensia to Showcase Latest Diagnostic Developments at the AACC Oak Ridge Conference.

Dublin, 16 April 2012.  Biosensia ltd., a point of care diagnostics Company, will be presenting two posters at this year’s AACC Oak Ridge Conference, ‘Emerging Technologies for 21st Century Clinical Diagnostics’, in San Jose.  The posters will illustrate a series of developments proving the effectiveness of Biosensia’s RapiPlex platform. RapiPlex, is a novel, user...


Xention Reports Positive Phase 1 Data for New Atrial Fibrillation Drug

March 22, 2012. CAMBRIDGE, UK – XENTION LTD, the Cambridge-based biopharmaceutical company specialising in the discovery and development of ion channel-modulating drugs, reported positive data today from a phase 1 trial of XEN-D0103 administered orally.  The drug, a selective inhibitor of the cardiac potassium channel Kv1.5, was well tolerated and demonstrated good...




< back to home page